What's New at The Body
HIV/AIDS News You Can Use
December 4, 2002
Plus, don't forget about our brand-new Art Action AIDS/Visual AIDS E-Cards! Send one to a friend to show you care, or use them as a tool to increase others' awareness of HIV.
"By raising awareness and promoting acceptance of people living with HIV/AIDS, we help improve the lives of millions of people around the world and demonstrate the compassion of our Nation." George W. Bush may not be doing much to prevent HIV in the U.S., but he did issue a Presidential proclamation of World AIDS Day 2002.Browse through this surprising, inspiring collection! changes in their menstrual cycles: unusually light or heavy amounts of bleeding, missed periods or no periods at all. What causes these changes, and what should you do about it if they happen to you? Find out in ACRIA's outstanding "Treatment Issues for Women" guide. Visit our busy bulletin boards at The Body's Community Center every day and talk about whatever's on your mind! Read the latest news about HIV from the 6th International Congress on Drug Therapy in HIV Infection:
An increasing number of studies have looked at starting HIV treatment with four drugs. One recent trial focused on patients with CD4 counts of mostly under 100. The results so far? After 24 weeks more than 50 percent of patients achieved viral loads below 50. Dr. Mark A. Wainberg reports.
Because of interactions, the once-daily pairing of tenofovir (Viread) and ddI (Videx) is still being studied. The latest trials show that tenofovir and ddI can be taken together without reducing ddI's potency, provided they're consumed with a light meal. Dr. Mark Nelson reports.
Dr. Mark A. Wainberg reports on the latest in HIV drug development.Larry Kramer writes about his new liver. here to read excerpts from Achmat's speech at the XIV International AIDS Conference. HIV among people under 35. marijuana smoke is more dangerous than cigarette smoke. AIDS Treatment News provides an analysis. online adherence survey yet, what are you waiting for? AIDS Action's interactive questionnaire will tell you just how well you're sticking to your HIV-treatment regimen. nevirapine to U.S. residents with low incomes. genetic test being developed in Australia may help predict whether a person will develop a dangerous hypersensitivity reaction to abacavir (Ziagen). funding crisis now threatening AIDS Drug Assistant Programs (ADAPs) throughout the U.S.? GMHC Treatment Issues discusses the ADAP emergency. reaching a group of people that can often be hard to target.
Arab World Must Not Rest in Battle Against AIDS
China's Deadly Cover-Up
The View at AIDS Ground Zero